跳到主要内容

PSYCHEMEDICS CORP (PMDI) Stock Forecast 2025 - AI Price Prediction & Analysis


PSYCHEMEDICS CORP (PMDI) AI Stock Price Forecast & Investment Analysis

PSYCHEMEDICS CORP Stock Price Chart and Technical Analysis

Loading PSYCHEMEDICS CORP interactive price chart and technical analysis...

PSYCHEMEDICS CORP (PMDI) - Comprehensive Stock Analysis & Investment Research

Deep dive into PSYCHEMEDICS CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about PSYCHEMEDICS CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For PSYCHEMEDICS CORP: PSYCHEMEDICS CORP operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

PSYCHEMEDICS CORP (Stock Symbol: PMDI) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Medical Laboratories industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing PSYCHEMEDICS CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For PSYCHEMEDICS CORP:

Market Capitalization: $13 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for PSYCHEMEDICS CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For PSYCHEMEDICS CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for PSYCHEMEDICS CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: PSYCHEMEDICS CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For PSYCHEMEDICS CORP: Market positioning analysis based on available financial and operational metrics.

PSYCHEMEDICS CORP strategically competes in the highly dynamic Services-Medical Laboratories marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

PSYCHEMEDICS CORP (PMDI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for PSYCHEMEDICS CORP stock analysis.

Loading PSYCHEMEDICS CORP comprehensive fundamental analysis and insider trading data...

Deep dive into PSYCHEMEDICS CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if PSYCHEMEDICS CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For PSYCHEMEDICS CORP:

P/B Ratio 2.56x
Market Cap $13M
EPS $-0.32
Book Value/Share $0.84
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently PSYCHEMEDICS CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For PSYCHEMEDICS CORP:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess PSYCHEMEDICS CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For PSYCHEMEDICS CORP:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal PSYCHEMEDICS CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For PSYCHEMEDICS CORP:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively PSYCHEMEDICS CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For PSYCHEMEDICS CORP:

Understanding Financial Statement Data

What these metrics mean: Key figures from PSYCHEMEDICS CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For PSYCHEMEDICS CORP:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 6M

Latest PSYCHEMEDICS CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting PSYCHEMEDICS CORP (PMDI) stock price and investment outlook.

, source: Yahoo Finance

ACTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today that its board of ...

, source: Forbes

Looking at the universe of stocks we cover at Dividend Channel, on 3/5/13, Psychemedics Corp. (NASD: PMD) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 3/21/13. As a ...

, source: Insider Monkey

Psychemedics Corp. (NASDAQ:PMD) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for PMD is 52.3.

PSYCHEMEDICS CORP Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of PSYCHEMEDICS CORP against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACON Unlock Forecast - 30 Days FREE Trial $3M 0.0x 1.2x
ACONW Unlock Forecast - 30 Days FREE Trial $0M x 0.2x
ADVB Unlock Forecast - 30 Days FREE Trial $9M x 2.2x
AMS Unlock Forecast - 30 Days FREE Trial $16M 5.2x 0.7x
BDSX Unlock Forecast - 30 Days FREE Trial $65M -3.0x 56.8x
BGLC Unlock Forecast - 30 Days FREE Trial $76M x 9.8x
BNR Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CAI Unlock Forecast - 30 Days FREE Trial $9785M 7.6x 21.6x
CDNA Unlock Forecast - 30 Days FREE Trial $757M 14.7x 2.3x
CELC Unlock Forecast - 30 Days FREE Trial $2672M -4.5x 60.2x
CSTL Unlock Forecast - 30 Days FREE Trial $683M -2110.5x 1.5x
DGX Unlock Forecast - 30 Days FREE Trial $20626M 21.7x 2.9x
EXAS Unlock Forecast - 30 Days FREE Trial $10197M -343.6x 4.1x
FLGT Unlock Forecast - 30 Days FREE Trial $680M 516.8x 0.6x
FTRE Unlock Forecast - 30 Days FREE Trial $914M -6.8x 1.6x
GH Unlock Forecast - 30 Days FREE Trial $7490M -8.9x -23.0x
GRAL Unlock Forecast - 30 Days FREE Trial $1353M x 0.6x
LH Unlock Forecast - 30 Days FREE Trial $23435M 30.7x 2.8x
NTRA Unlock Forecast - 30 Days FREE Trial $24120M -74.2x 19.4x
PMD Unlock Forecast - 30 Days FREE Trial $12M -5.7x 2.2x
PMDI Unlock Forecast - 30 Days FREE Trial $13M x 2.6x
PSNL Unlock Forecast - 30 Days FREE Trial $465M -2.3x 2.4x
RDNT Unlock Forecast - 30 Days FREE Trial $6835M 462.8x 7.3x
RENXF Unlock Forecast - 30 Days FREE Trial $10M x x
RNLXY Unlock Forecast - 30 Days FREE Trial $28M x x
SERA Unlock Forecast - 30 Days FREE Trial $152M -9.0x 1.7x
VCYT Unlock Forecast - 30 Days FREE Trial $2531M 96.1x 2.1x
XGN Unlock Forecast - 30 Days FREE Trial $213M -5.4x 10.1x

Frequently Asked Questions - PSYCHEMEDICS CORP Stock Forecast

How accurate are PSYCHEMEDICS CORP stock predictions?

Our AI model demonstrates 41% historical accuracy for PMDI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence PSYCHEMEDICS CORP stock price forecasts?

Our analysis considers PSYCHEMEDICS CORP's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is PSYCHEMEDICS CORP a good investment in 2025?

Based on our AI analysis, PSYCHEMEDICS CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are PSYCHEMEDICS CORP forecasts updated?

PSYCHEMEDICS CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced PSYCHEMEDICS CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for PSYCHEMEDICS CORP stock.

My Portfolio

Investment Dashboard

Loading your portfolio...